Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study

OBJECTIVE: PARADIGMS demonstrated superior efficacy and comparable safety of fingolimod versus interferon β-1a (IFN β-1a) in paediatric-onset multiple sclerosis (PoMS). This study aimed to report all predefined MRI outcomes from this study. METHODS: Patients with multiple sclerosis (MS) (aged 10–<...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurol Neurosurg Psychiatry
Main Authors: Arnold, Douglas L, Banwell, Brenda, Bar-Or, Amit, Ghezzi, Angelo, Greenberg, Benjamin M, Waubant, Emmanuelle, Giovannoni, Gavin, Wolinsky, Jerry S, Gärtner, Jutta, Rostásy, Kevin, Krupp, Lauren, Tardieu, Marc, Brück, Wolfgang, Stites, Tracy E, Pearce, Gregory L, Häring, Dieter A, Merschhemke, Martin, Chitnis, Tanuja
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Multiple Sclerosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231437/
https://ncbi.nlm.nih.gov/pubmed/32132224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2019-322138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados